Skip to main content

AEVEX Corp.

For the period ended Mar 31, 2026. Filed May 20, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 20, 2026

AVEX$11.60+0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows (Unaudited)

(In thousands)

Three Months Ended March 31,
20262025
Operating activities
Net income (loss)$20,998$(27,322)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization5,3095,173
Amortization of debt issuance costs90301
Stock compensation expense3944
Change in contingent consideration-1,221
Deferred income taxes-33
Noncash operating lease expense820781
Provision for inventory obsolescence67358
Change in fair value of derivative liability2,400-
Gain on sale of equipment(48)-
Changes in operating assets and liabilities:
Accounts receivable, net(30,371)(19,139)
Contract assets(41,021)9,359
Inventories(2,034)(1,785)
Prepaid expenses and other current assets3,518(1,031)
Other assets(12)340
Accounts payable21,4105,733
Accrued expenses and other current liabilities(927)5,504
Deferred revenue10,2481,058
Operating lease liabilities(837)(776)
Net cash used in operating activities(10,351)(20,148)
Investing activities
Business acquisition, net of cash acquired(500)(2,077)
Purchases of property and equipment(1,250)(1,643)
Net cash used in investing activities(1,750)(3,720)
Financing activities
Proceeds from Series A preferred units, net of issuance costs15,317-
Repurchase of Class A units(1,048)-
Distributions to noncontrolling interest(75)(68)
Repayment of notes payable(680)(680)
Payments of deferred offering costs(1,872)-
Net cash provided by (used in) financing activities11,642(748)
Net decrease in cash and cash equivalents(459)(24,616)
Cash and cash equivalents:
Beginning of period27,90845,603
End of period$27,449$20,987
Supplemental disclosures of cash flow information:
Cash paid for interest$6,340$6,820
Supplemental disclosures of noncash financing and investing activities:
Purchase of property and equipment in accounts payable and accrued expenses$829$510
Series A preferred units accretion1,362-
Deferred offering costs in accounts payable and accrued expenses4,726-
Deferred financing costs in accrued expenses1,100-
Right-of-use assets obtained in exchange for new lease liabilities445573
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.